| AKRO |    | Akero Therapeutics, Inc. - Common Stock | | | 4.05% up -15.1% 19.15 | | + Disease: Liver, Medicine
Last highlighted: #AKRO SEC report: Akero Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Akero Therapeutics, Inc. -- SEC File Number | + My List |
| BIVI | | BioVie Inc. - Common stock | | | -7.72% -7.72% 0 | | + Medicine, Disease: Liver
| + My List |
| CARA | | Cara Therapeutics, Inc. - Common Stock | | | 2.98% up -10.55% 13.53 | | + Medicine, Disease: Kidney, Disease: Liver, Skin, Dermatology
Last highlighted: Form 8-K: Regulation FD Disclosure. On April 29, 2021, Cara Therapeutics issued a press release announcing topline.. $CARA https://t.co/cUtiqqrXat | + My List |
| DCTH | | Delcath Systems, Inc. - Common Stock | | | 2.04% up -7.08% 9.12 | | + Cancer fight, Medicine, Disease: Liver
Last highlighted: #DCTH SEC report: DELCATH SYSTEMS, INC. Notice of Effectiveness | + My List |
| DRRX | | DURECT Corporation - Common Stock | | | 0 | | + Biopharma, Disease: Liver, Medicine
Last highlighted: $DRRX New Form 8-K for DURECT Corporation
From our Stock News Alerts App | + My List |
| ETNB | | 89bio, Inc. - Common Stock | | | up -8.01% 8.01 | | + Biopharma, Disease: Liver, Medicine
| + My List |
| GALT | | Galectin Therapeutics Inc. - Common Stock | | | -2.88% up -7.35% 4.47 | | + Cancer fight, Disease: Liver, Skin, Medicine
Last highlighted: #GALT SEC report: GALECTIN THERAPEUTICS INC Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by GALECTIN THERAPEUTICS INC -- SEC File Number 211081679 | + My List |
| GLMD | | Galmed Pharmaceuticals Ltd. - Ordinary Shares | | | 0 | | + Disease: Liver, Biopharma, Country: Israel, Medicine
Last highlighted: Galmed Pharmaceuticals Ltd current quarter revenue growth YoY of 96.40% ranked 256 out of 5424 companies in our database.
https://t.co/R7UW3RpPpw $GLMD
🚀🚀🚀🚀🚀 https://t.co/HVbvEgerWf | + My List |
| GNFT | | GENFIT S.A. - American Depositary Shares | | | 0.82% down 23.6% -22.78 | | + Biopharma, Disease: Liver, Medicine
| + My List |
| ICPT | | Intercept Pharmaceuticals, Inc. - Common Stock | | | 0.48% up -9.64% 10.12 | | + Pharmaceutical , Medicine, Biopharma, Disease: Liver
Last highlighted: #ICPT SEC report: INTERCEPT PHARMACEUTICALS, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by INTERCEPT PHARMACEUTICALS, INC. -- SEC File Number | + My List |
| NDRA | | ENDRA Life Sciences Inc. - Common Stock | | | 0 | | + Life Sciences, Disease: Liver
| + My List |
| TERN | | Terns Pharmaceuticals, Inc. - Common Stock | | | 1.27% 1.27% 0 | | + Biopharma, Pharmaceutical , Disease: Liver
Last highlighted: $TERN 8-K Terns Pharmaceuticals (14 Jun, 4:40pm)
📰 Terns Reports Positive Top-line Results from Phase 2a LIFT Study of FXR Agonist TERN-101 in Patients with NASH
https://t.co/wJNwFxLOZw
#TERN #8K #TernsPharmaceuticals #News | + My List |